Oncology Specialists, S.C.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer

Phase 2

Terminated

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: Oxaliplatin + Docetaxel

First Posted Date: 2005-09-05

Last Posted Date: 2014-06-30

Lead Sponsor: Oncology Specialists, S.C.

Target Recruit Count: 15

Registration Number: NCT00145418

Locations: 🇺🇸
Oncology Specialists, SC, Park Ridge, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy